Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Extrapleural pneumonectomy for thoracic malignancies].

Kohei Yokoi1, H Matsuguma, R Nakahara

  • 1Division of General Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|October 30, 2004
PubMed
Summary

Extrapleural pneumonectomy is a viable surgical option for select patients with lung cancer and thymoma, offering potential for cure. While effective for thymoma, its efficacy for malignant pleural mesothelioma requires further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large nonlinear optical magnetoelectric response in a noncentrosymmetric magnetic Weyl semimetal.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.

International journal of molecular sciences·2024
Same author

Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Effect of proton pump inhibitors on the development of hypomagnesemia induced by panitumumab.

Die Pharmazie·2022
Same author

Pleural Invasion Depth of Disseminated Nodules in Patients with Stage IVa or Recurrent Thymoma: Assessment, Curative Impact, and Surgical Outcomes.

Annals of surgical oncology·2021
Same author

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Journal of the National Cancer Institute·2021

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology

Context:

  • Extrapleural pneumonectomy (EP) is a complex thoracic surgical procedure.
  • Historically used for malignant pleural mesothelioma and tuberculous empyema.
  • Recently explored for carcinomatous pleuritis in lung cancer and thymoma.

Purpose:

  • To evaluate the safety and efficacy of extrapleural pneumonectomy in patients with thoracic malignancies.
  • To assess survival outcomes for lung cancer, thymoma, and malignant pleural mesothelioma patients undergoing EP.

Summary:

  • This study involved 24 patients with thoracic malignancies (lung cancer, thymoma, mesothelioma) who underwent extrapleural pneumonectomy.
  • All patients survived the surgery with manageable complications (hemorrhage, empyema).
  • Positive outcomes were observed in lung cancer and thymoma patients, with promising survival rates and disease-free survival, respectively. Mesothelioma patients had poorer survival.

Related Experiment Videos

Impact:

  • Extrapleural pneumonectomy may be a curative option for carefully selected patients with carcinomatous pleuritis of lung cancer and thymoma.
  • The findings suggest potential benefits for specific thoracic malignancy cases.
  • Further prospective studies are needed to confirm the long-term value of EP in these indications.